NCT00230399View on ClinicalTrials.gov

Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

January 31, 2006

Study Completion Date

March 31, 2008

Conditions
Colorectal Cancer
Interventions
DRUG

Celecoxib

DRUG

Capecitabine

DRUG

Irinotecan

Trial Locations (1)

48109

University of Michigan Cancer Center, Ann Arbor

All Listed Sponsors
lead

University of Michigan Rogel Cancer Center

OTHER

NCT00230399 - Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter